Barclays PLC Centogene N.V. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

A detailed history of Barclays PLC transactions in Centogene N.V. stock. As of the latest transaction made, Barclays PLC holds 15,348 shares of CNTG stock, worth $1,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,348
Previous 15,348 -0.0%
Holding current value
$1,688
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$0.72 - $1.28 $223 - $396
-310 Reduced 1.98%
15,348 $14,000
Q3 2022

Nov 03, 2022
SELL
$1.11 - $2.78 $351 - $881
-317 Reduced 1.98%
15,658 $18,000
Q2 2022

Aug 12, 2022
SELL
$2.06 - $4.25 $150 - $310
-73 Reduced 0.45%
15,975 $38,000
Q1 2022

May 16, 2022
BUY
$3.3 - $5.44 $52,958 - $87,301
16,048 New
16,048 $68,000

Others Institutions Holding CNTG

# of Institutions
2
Shares Held
33.6K
Call Options Held
0
Put Options Held
0
View Full List

About Centogene N.V.

CNTG Quotes by TradingView
  • Ticker CNTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,081,600
  • Market Cap $2.98M
  • Description
  • Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...
More about CNTG
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email